The top pre-market NASDAQ stock market losers are: LTX-Credence, BroadSoft, Cninsure, YRC Worldwide, Human Genome Sciences, Celgene, Identive Group, Randgold Resources, Qiagen, and Corinthian Colleges.

LTX-Credence Corp. (LTXC) lost 7.69 percent to $7.80 in the pre-market trading. The company swiftly responded to Verigy, Ltd.'s (VRGY) announcement Monday regarding Advantest's 'unsolicited' proposal to buy Verigy, saying that it expected to close its merger agreement with Verigy, inked on November 17, 'much sooner than any potential acquisition of Verigy by Advantest'.

Verigy still believes in the 'compelling strategic and financial merits' of its proposed transaction with LTX-Credence and still recommends the transaction to its shareholders. Verigy said its board has not withdrawn its recommendation with respect to the LTX-Credence transaction or does not propose to do so, and is not making any recommendation with respect to the Advantest offer.

BroadSoft, Inc. (BSFT) tumbled 5.82 percent to $23.61 in the pre-market session. The company said it filed a registration statement on Form S-1 with SEC for a proposed public offering of 5 million shares of its common stock.

Cninsure Inc. (CISG) plunged 4.32 percent to $16.06 in the pre-market trading.

YRC Worldwide Inc. (YRCW) plummeted 3.41 percent to $3.12 in the pre-market session.

Human Genome Sciences Inc. (HGSI) fell 3.13 percent to $24.80 in the pre-market trading. The company and GlaxoSmithKline Plc (GSK) said the U.S. FDA has extended the target date to approve its Benlysta as a potential treatment for systemic lupus erythematosus to March 10, 2011.

Celgene Corp. (CELG) dropped 2.95 percent to $58.80 in the pre-market session. The company announced Revlimid data in patients with multiple myeloma evaluating survival rates with low- and high-dose dexamethasone with respect to age.

Identive Group, Inc. (INVE) declined 2.56 percent to $2.28 in the pre-market session.

Randgold Resources Ltd. (GOLD) decreased 2.33 percent to $91.41 in the pre-market trading.

Qiagen NV (QGEN) moved down 1.57 percent to $18.78 in the pre-market session.

Corinthian Colleges Inc. (COCO) fell 1.35 percent to $4.37 in the pre-market trading.

Gold SEC NASDAQ Stock Market Glaxosmithkline